Bosentan and Glyburide and metformin interaction

Bosentan and Glyburide and metformin: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Bosentan (Tracleer) label · effective 2025-11-17

Major

Use with Glyburide ( 4.3 ).

Contraindicationsnames Glyburide and metforminView label on DailyMed
Major

Use with Glyburide An increased risk of liver enzyme elevations was observed in patients receiving glyburide concomitantly with bosentan.

Contraindicationsnames Glyburide and metforminView label on DailyMed
Major

Therefore co-administration of glyburide and TRACLEER is contraindicated [see Drug Interactions (7.1) ] .

Contraindicationsnames Glyburide and metforminView label on DailyMed

From the Glyburide and metformin (glyburide and metformin hydrochloride) label · effective 2026-06-10

Major

Concomitant administration of bosentan [see Drug Interactions ( 7 ) ].

Contraindicationsnames BosentanView label on DailyMed
Major

Concomitant administration of bosentan.

Contraindicationsnames BosentanView label on DailyMed
Moderate

Bosentan Clinical Impact: Increased risk of liver enzyme elevations was observed.

Drug interactionsnames BosentanView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.